Home › Dolomite's Microfluidics Technology Helping to Advance Antibody Therapeutics
 

Keywords :   


Dolomite's Microfluidics Technology Helping to Advance Antibody Therapeutics

2015-01-16 11:30:53| Industrial Newsroom - All News for Today

Dolomite's droplet generation system is helping AbVitro to identify potential therapeutic targets using its AbPair technology. Dr Adrian Briggs, Director of Molecular Biology RD at AbVitro, commented: "Our aim is to develop new potential targets and therapies for a wide range of diseases, taking advantage of the...

Tags: technology advance helping antibody

Category:Industrial Goods and Services

Latest from this category

All news
17.05Next MANAchat Series Scheduled for the Week of June 10
15.05Relationship Reviews Strengthening the Partnership Between Manufacturer and Rep
14.05Consolidated Financial Statements for the twelve-month period ended March 31, 2024
14.05Actions to Implement Management that is Conscious of Cost of Capital and Stock Price
Industrial Goods and Services »
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
More »